Status:
NOT_YET_RECRUITING
The Impact of Commercial Blenderized Formula on Caloric Needs, Gastrointestinal Symptoms, and Gut Microbiome in Children With Cerebral Palsy (CP)
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Cerebral Palsy
Eligibility:
All Genders
3-18 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the Pediatric Quality of Life Inventory Gastrointestinal Symptoms Scale Gastrointestinal Symptoms Scale (GI-PedsQL) differences , to assess the differences in s...
Eligibility Criteria
Inclusion
- Patients with CP receiving \>75% of total daily caloric requirements from commercial formulas (CF) via a gastrostomy tube 12french or greater
- Patients' insurance covers a CBTF
- Diagnosis of cerebral palsy
Exclusion
- Receiving enteral nutrition by transpyloric feeds or jejunal tube.
- Receiving \<75% of total daily energy requirements from a commercial formula
- Weight or weight for length or body mass index less than the 5th percentile for age or greater than the 85th% percentile for age when plotted on the cerebral palsy growth chart
- Rapidly progressive neurodegenerative disease diagnosis
- Use of monomeric formulas
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06488560
Start Date
August 1 2024
End Date
December 31 2024
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030